These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 26657879)

  • 1. Bridge therapy or standard treatment for urgent surgery after coronary stent implantation: Analysis of 314 patients.
    De Servi S; Morici N; Boschetti E; Rossini R; Martina P; Musumeci G; D'Urbano M; Lazzari L; La Vecchia C; Senni M; Klugmann S; Savonitto S
    Vascul Pharmacol; 2016 May; 80():85-90. PubMed ID: 26657879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term follow-up of tirofiban as alternative therapy for urgent surgery patients with an implanted coronary drug-eluting stent after ST-elevation myocardial infarction.
    Xia JG; Qu Y; Shen H; Liu XH
    Coron Artery Dis; 2013 Sep; 24(6):522-6. PubMed ID: 23900046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Net clinical benefit of prehospital glycoprotein IIb/IIIa inhibitors in patients with ST-elevation myocardial infarction and high risk of bleeding: effect of tirofiban in patients at high risk of bleeding using CRUSADE bleeding score.
    Hermanides RS; Ottervanger JP; ten Berg JM; Gosselink AT; van Houwelingen G; Dambrink JH; Stella PR; Hamm C; van 't Hof AW;
    J Invasive Cardiol; 2012 Mar; 24(3):84-9. PubMed ID: 22388296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiplatelet effect of ticagrelor compared to tirofiban in non-ST-segment elevation ACS patients undergoing PCI. The result of the TE-CLOT trial.
    Kim JS; Han DC; Jeong YH; Park DW; Sohn CB; Hwang KW; Lee SH; Choi JH; Chon MK; Lee SY; Hwang J; Kim IS; Lee SM; Han J; Noh M; Kim CH; Chun KJ; Park YH; Kim JH
    Thromb Haemost; 2016 Jan; 115(1):213-21. PubMed ID: 26581884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perioperative management of antiplatelet therapy in patients with coronary stents undergoing cardiac and non-cardiac surgery: a consensus document from Italian cardiological, surgical and anaesthesiological societies.
    Rossini R; Musumeci G; Visconti LO; Bramucci E; Castiglioni B; De Servi S; Lettieri C; Lettino M; Piccaluga E; Savonitto S; Trabattoni D; Capodanno D; Buffoli F; Parolari A; Dionigi G; Boni L; Biglioli F; Valdatta L; Droghetti A; Bozzani A; Setacci C; Ravelli P; Crescini C; Staurenghi G; Scarone P; Francetti L; D'Angelo F; Gadda F; Comel A; Salvi L; Lorini L; Antonelli M; Bovenzi F; Cremonesi A; Angiolillo DJ; Guagliumi G; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ;
    EuroIntervention; 2014 May; 10(1):38-46. PubMed ID: 24832636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiplatelet therapy in acute coronary syndromes.
    Aragam KG; Bhatt DL
    J Cardiovasc Pharmacol Ther; 2011 Mar; 16(1):24-42. PubMed ID: 20924098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Timing of coronary stent thrombosis in patients treated with prophylactic tirofiban.
    Assali AR; Sdringola S; Ghani M; Westbrook LA; Anderson HV; Schroth G; Fujise K; Smalling RW; Rosales OR
    J Invasive Cardiol; 2000 Sep; 12(9):460-3. PubMed ID: 10973371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prasugrel versus tirofiban bolus with or without short post-bolus infusion with or without concomitant prasugrel administration in patients with myocardial infarction undergoing coronary stenting: the FABOLUS PRO (Facilitation through Aggrastat By drOpping or shortening Infusion Line in patients with ST-segment elevation myocardial infarction compared to or on top of PRasugrel given at loading dOse) trial.
    Valgimigli M; Tebaldi M; Campo G; Gambetti S; Bristot L; Monti M; Parrinello G; Ferrari R;
    JACC Cardiovasc Interv; 2012 Mar; 5(3):268-77. PubMed ID: 22440491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Periprocedural use of tirofiban in elective percutaneous coronary intervention for long coronary lesions in stable patients with overlapping drug-eluting stents--the PETITION study: a prospective, randomized, multicenter study.
    Zhang Q; Wang XL; Liao ML; Hu J; Yang ZK; Ding FH; Zhang JS; Du R; Zhu TQ; Shen WF; Zhang RY
    Catheter Cardiovasc Interv; 2015 Mar; 85 Suppl 1():762-9. PubMed ID: 25630513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: the MULTISTRATEGY randomized trial.
    Valgimigli M; Campo G; Percoco G; Bolognese L; Vassanelli C; Colangelo S; de Cesare N; Rodriguez AE; Ferrario M; Moreno R; Piva T; Sheiban I; Pasquetto G; Prati F; Nazzaro MS; Parrinello G; Ferrari R;
    JAMA; 2008 Apr; 299(15):1788-99. PubMed ID: 18375998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perioperative use of tirofiban hydrochloride (Aggrastat) does not increase surgical bleeding after emergency or urgent coronary artery bypass grafting.
    Bizzarri F; Scolletta S; Tucci E; Lucidi M; Davoli G; Toscano T; Neri E; Muzzi L; Frati G
    J Thorac Cardiovasc Surg; 2001 Dec; 122(6):1181-5. PubMed ID: 11726894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Coronary stenting and surgery: perioperative management of antiplatelet therapy in patients undergoing surgery after coronary stent implantation].
    Rossini R; Bramucci E; Castiglioni B; De Servi S; Lettieri C; Lettino M; Musumeci G; Visconti LO; Piccaluga E; Savonitto S; Trabattoni D; Buffoli F; Angiolillo DJ; Bovenzi F; Cremonesi A; Scherillo M; Guagliumi G; ;
    G Ital Cardiol (Rome); 2012; 13(7-8):528-51. PubMed ID: 22781382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of glycoprotein IIb-IIIa receptor antagonism on platelet membrane glycoproteins after coronary stent placement.
    Gawaz M; Ruf A; Neumann FJ; Pogátsa-Murray G; Dickfeld T; Zohlnhöfer D; Schömig A
    Thromb Haemost; 1998 Dec; 80(6):994-1001. PubMed ID: 9869173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet inhibition by abciximab bolus-only administration and oral ADP receptor antagonist loading in acute coronary syndrome patients: the blocking and bridging strategy.
    Christ G; Hafner T; Siller-Matula JM; Francesconi M; Grohs K; Wilhelm E; Podczeck-Schweighofer A
    Thromb Res; 2013 Jul; 132(1):e36-41. PubMed ID: 23791395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perioperative Bridging With Glycoprotein IIb/IIIa Inhibitors Versus Cangrelor: Balancing Efficacy and Safety.
    Van Tuyl JS; Newsome AS; Hollis IB
    Ann Pharmacother; 2019 Jul; 53(7):726-737. PubMed ID: 30646761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of a preoperative "bridging" strategy with glycoprotein IIb/IIIa inhibitors to prevent perioperative stent thrombosis in patients with drug-eluting stents who undergo surgery necessitating interruption of thienopyridine administration.
    Alshawabkeh LI; Prasad A; Lenkovsky F; Makary LF; Kandil ES; Weideman RA; Kelly KC; Rangan BV; Banerjee S; Brilakis ES
    EuroIntervention; 2013 Jun; 9(2):204-11. PubMed ID: 23454910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization.
    Topol EJ; Moliterno DJ; Herrmann HC; Powers ER; Grines CL; Cohen DJ; Cohen EA; Bertrand M; Neumann FJ; Stone GW; DiBattiste PM; Demopoulos L;
    N Engl J Med; 2001 Jun; 344(25):1888-94. PubMed ID: 11419425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bridging with Tirofiban during Oral Antiplatelet Interruption: A Single-Center Case Series Analysis Including Patients on Hemodialysis.
    Walker EA; Dager WE
    Pharmacotherapy; 2017 Aug; 37(8):888-892. PubMed ID: 28543216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Perioperative management and postoperative complication rates of patients on dual antiplatelet therapies after coronary drug eluting stent implantation].
    Komiya R; Kamintani K; Kubo E; Hattori M; Kataoka H; Iwase Y; Miyoshi H; Minami M; Kato S; Arai R; Yoshida H
    Masui; 2014 Jun; 63(6):629-35. PubMed ID: 24979851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unplanned surgery after drug eluting stent implantation: a strategy for safe temporary withdrawal of dual oral antiplatelet therapy.
    D'Urbano M; Barlocco F; Poli A; Fetiveau R; Vandoni P; Savonitto S; De Servi S
    J Cardiovasc Med (Hagerstown); 2008 Jul; 9(7):737-41. PubMed ID: 18545078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.